METASTATIC PAPILLARY RENAL CELL CARCINOMA
Clinical trials for METASTATIC PAPILLARY RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PAPILLARY RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PAPILLARY RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to outsmart Hard-to-Treat kidney cancer
Disease control OngoingThis phase II trial tests whether adding the immunotherapy drug atezolizumab to the standard drug cabozantinib helps people with advanced papillary kidney cancer live longer without their disease getting worse. About 200 participants will receive either cabozantinib alone or cabo…
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Gut bacteria booster may help kidney cancer drugs work better
Disease control OngoingThis early-phase trial is testing whether adding a probiotic called CBM588 to the standard combination of cabozantinib and nivolumab can improve treatment for advanced or metastatic kidney cancer. The probiotic is designed to restore helpful gut bacteria that may help the immune …
Matched conditions: METASTATIC PAPILLARY RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC